入院时PCO2作为院外心脏骤停患者的预测生物标志物
该单中心回顾性研究纳入2016年1月至2020年12月收治的778例成人院外心脏骤停(OHCA)患者,评估入院时PCO2与1个月预后的关联。主要结局为1个月死亡(CPC 5),发生于706例(90.7%);死亡或不良神经预后(CPC 3-5)743例(95.5%),不良神经预后(CPC 3-4)37例(4.8%)。多因素分析校正年龄、性别、目击骤停、旁观者心肺复苏、初始可除颤心律及呼叫至到院时间后,PCO2每升高5 mmHg与死亡(OR 1.14,95%CI 1.08-1.21)、死亡或不良神经预后(OR 1.29,95%CI 1.17-1.42)及不良神经预后(OR 1.21,95%CI 1.04-1.41)显著相关。提示入院时PCO2可能有助于早期风险分层。
要点
- 778例成人OHCA患者中,1个月死亡(CPC 5)706例(90.7%),死亡或不良神经预后(CPC 3-5)743例(95.5%),不良神经预后(CPC 3-4)37例(4.8%)。
- 多因素分析校正年龄、性别、目击骤停、旁观者心肺复苏、初始可除颤心律及呼叫至到院时间后,PCO2每升高5 mmHg与1个月死亡独立相关(OR 1.14,95%CI 1.08-1.21)。
- PCO2每升高5 mmHg与1个月死亡或不良神经预后(CPC 3-5)相关(OR 1.29,95%CI 1.17-1.42)。
- PCO2每升高5 mmHg与1个月不良神经预后(CPC 3-4)相关(OR 1.21,95%CI 1.04-1.41)。
- 研究为单中心回顾性设计,PCO2对预后的预测价值需进一步研究确认。
适用人群与场景
- 成人院外心脏骤停(OHCA)患者,收治于单中心,研究期间为2016年1月至2020年12月。
- 排除年龄<18岁者19例、接受体外心肺复苏者79例、缺乏PCO2数据者101例。
诊断标准与关键阈值
- 预后采用脑功能分类(CPC)量表定义:死亡为CPC 5;死亡或不良神经预后为CPC 3-5;不良神经预后为CPC 3-4。
研究设计与关键结果
- 单中心回顾性研究,研究期间977例OHCA患者中排除19例年龄<18岁、79例接受体外心肺复苏、101例缺乏PCO2数据,最终纳入778例。
- 1个月死亡(CPC 5)706例(90.7%),死亡或不良神经预后(CPC 3-5)743例(95.5%),不良神经预后(CPC 3-4)37例(4.8%)。
- 多因素分析校正年龄、性别、目击骤停、旁观者心肺复苏、初始可除颤心律及呼叫至急救医疗服务至到院时间后,入院时高PCO2与1个月死亡(CPC 5)显著相关(每5 mmHg OR 1.14,95%CI 1.08-1.21)。
- 入院时高PCO2与1个月死亡或不良神经预后(CPC 3-5)显著相关(每5 mmHg OR 1.29,95%CI 1.17-1.42)。
- 入院时高PCO2与1个月不良神经预后(CPC 3-4)显著相关(每5 mmHg OR 1.21,95%CI 1.04-1.41)。
证据类型、等级与局限
- 证据类型:单中心回顾性研究。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为,入院时高PCO2与OHCA患者死亡及不良神经预后显著相关,可能有助于早期预后评估。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: Treating patients with out-of-hospital cardiac arrest (OHCA) requires early prediction of outcome, ideally on hospital arrival, as it can inform the clinical decisions involved. This study evaluated whether partial pressure of carbon dioxide (PCO2) on arrival is associated with outcome at one month OHCA patients.
METHODS: This was a single-center retrospective study of adult OHCA patients treated between January 2016 and December 2020. Outcomes were defined along the Cerebral Performance Category (CPC) scale. Primary outcome was mortality (CPC 5) at one month. Secondary outcomes were death or unfavorable neurological outcome (CPC 3-5) and unfavorable neurological outcome (CPC 3-4) at one month. Multivariable analysis was adjusted for age, sex, witnessed cardiac arrest, bystander cardiopulmonary resuscitation, initial shockable rhythm, and time from call to emergency medical services to hospital arrival.
RESULTS: Out of 977 OHCA patients in the study period, 19 were excluded because they were aged under 18 years, 79 because they underwent extracorporeal cardiopulmonary resuscitation, and 101 due to lack of PCO2 data. This study included 778 patients total; mortality (CPC 5) at one month was observed in 706 (90.7%), death or unfavorable neurological outcome (CPC 3-5) in 743 (95.5%), and unfavorable neurological outcome (CPC 3-4) in 37 (4.8%). In multivariable analysis, high PCO2 levels showed significant association with mortality (CPC 5) at one month (odds ratio [OR] [per 5 mmHg], 1.14; 95% confidence interval [CI], 1.08-1.21), death or unfavorable neurological outcome (CPC 3-5) (OR [per 5 mmHg], 1.29; 95% CI, 1.17-1.42), and unfavorable neurological outcome (CPC 3-4) (OR [per 5 mmHg], 1.21; 95% CI, 1.04-1.41).
CONCLUSIONS: High PCO2 on arrival was significantly associated with mortality and unfavorable neurological outcome in OHCA patients.
参考来源
- Inoue F, Inoue A, Nishimura T, et al. PCO2 on arrival as a predictive biomarker in patients with out-of-hospital cardiac arrest. Am J Emerg Med. 2023. PMID: 37084483. doi:10.1016/j.ajem.2023.04.014
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。